Exam Two - Key Foundational Concepts Flashcards

1
Q

Pharmacology

A

study of drugs, actions, and reaction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

PD

A

pharmacodynamics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pharmacodynamics

A

“What the drug does to the body” this can be the desired therapeutic response, physiologic changes as well as adverse reactions/toxicities

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

PK

A

Pharmacokinetics

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pharmacokinetcs

A

“What the body does to the drug” full range of absorption, distribution, metabolism and excretion (ADME). May also include accumulation/toxicity

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pharmacy

A

involves therapeutic use of drugs as well as medication safety, inventory control and distribution systems

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

does-response relationships

A

as drug concentration increases, some maximal effect is reached (Emax)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

At half maximal effect

A

EC50
a description of potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Graded dose-response curve

A

degree of response varies with dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Quantal dose-response curve

A

average effect of a drug as a function of concentration in a given population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

effective (efficacious)

A

the ability of a drug to produce the desired effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Therapeutic Index (TI)

A

a range (index) of drug concentrations/doses needed to produce DESIRED THERAPEUTIC EFFECTS BELOW the level required to produce significant TOXICITY

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Therapeutic Window

A

want wide therapeutic windows. This means we have a lots of dosing room for desired effects before we hit toxicity. “safer” than those with narrow windows

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Narrow TI

A

drugs that have a small “dosing range”. The therapeutic dose is often only slightly above the non-effective dose and only slightly below a toxic dose.

careful dosing calculations/monitoring required for safe use

small dose changes may produce BIG concentration changes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Examples of narrow TI drugs

A

some seizure meds, gidoxin, aminoglycoside ABX, some chemo agents, lithium, warfarin, etc

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Formula for TI

A

TI = TD50/ED50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is an example for an Alpha 1 agonist?

A

vasopressor support

18
Q

What is an example for Beta agonists?

A

inhalers for asthma and copd

19
Q

other examples of drugs working via receptors

A

histamine H1 & H2 receptors
muscarinic receptors

20
Q

Physiological effects and opioid receptors

A

mu, kappa, and delta receptors

21
Q

Mu receptors are responsible for

A
  • analgesia
  • respiratory depression
    -Euphoria
  • sedation
  • physical dependence
  • slowed GI transit
  • miosis
    -modulation of hormone and NT release
22
Q

Kappa receptors are responsible for

A

-analgesia
-minimal respiratory depression
- dysphoria
-mild sedation
-slowed GI transit
-miosis
-psychomimetic effects

23
Q

delta receptors are responsible for

A

-analgesia
-modulation of hormone and NT release

24
Q

Explain why we need dose tapering

A

receptor density on a cell can become upregulated or downregulated. If a drug chronically blocks a receptor, the cell will make more of that receptor. If you suddenly take away the drug, the cell will have way too many receptors which could have disastrous consequences (ex. beta blockers)

25
Q

Agonist

A

binds to a receptor and mimics the natural/typical action of a NT or other endogenous agent.

26
Q

Antagonist

A

binds to the receptor and blocks or attenuates the natural response to NT or endogenous chemical

27
Q

Partial agonist

A

binds the receptor, elicits some/sub-maximal response BUT, inherent binding may also block natural action of endogenous NTs/chemicals which can in the grand scheme… actually attenuates an agonistic response! this may be useful for over-active endogenous conditions of reducing side effects

28
Q

Why should we care about drugs?

A

-impacts to tests to therapy!
-can alter exercise tolerance, diagnostic testing, falls, hypotension, diabetics

29
Q

Adverse drug side effects

A

common, range from annoying to dangerous
-dizziness, drowsiness, weakness, low blood pressure, reduced/blunted HR, hypoglycemia, nausea, vomiting, diarrhea, constipation, etc

30
Q

Patient management of adverse drug effects

A

dose timing, consideration of meal times, separating drugs from testing or therapy, use snacks, monitory HR/BP

31
Q

Adverse drug-food interactions

A

common, impact absorption after PO dose - may be related to di/trivalent cations, pH, vitamins/cofactors or other chemical interactions

32
Q

patient management of adverse drug-food interactions

A

separate drug dose from offending food/drink, some meds require reducing/eliminating or at least being consistent with certain foods/drinks

33
Q

Metronidazole

A

an antibiotic that has a strong drug-food interaction with alcohol of any kind. alcohol including mouthwash, perfume, aftershave, etc.

34
Q

Drug drug interactions

A

common, to mild, to life threatening

35
Q

PD interactions

A

antagonistic effects, additive or synergistic effects (EX - BP/HR drops too low or stimulant with a sedative)

36
Q

Chemical incompatibility interactions

A

predominately with parenteral agents, precipitates, Di/Tri-valent cations with some common oral meds, consult pharmacy!

37
Q

PK interactions

A

ADME - especially drug metabolism in liver (cyp P450/clearance)

38
Q

Old drug classification for pregnancy/lactating

A

A - human studies OK
B - Animal studies OK
C - animal studies MAY show harm, no human studies but benefit may outweigh risk
D - “Don’t”… evidence of human risk, may have benefit
X - evidence of human risk, benefits DON’T outweigh

39
Q

updated drug classification for preg/lac

A

narrative

40
Q
A